<DOC>
	<DOC>NCT01251302</DOC>
	<brief_summary>To investigate whether the use of a gene expression score blood assay changes the diagnostic testing pattern in patients referred to a cardiologist for the evaluation of chest pain or anginal equivalent symptoms.</brief_summary>
	<brief_title>Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern (IMPACT-CARD)</brief_title>
	<detailed_description>A prospective cohort of 88 subjects receiving the gene expression score assay were compared to a retrospective cohort of 83 subjects that did not receive the assay.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>1. Stable chest pain, typical or atypical angina or anginal equivalent 2. The patient has signed the appropriate Institutional Review Board approved Informed Consent Form. 1. History of myocardial infarction 2. Current myocardial infarct (MI) or acute coronary syndrome 3. Current New York Heart Association (NYHA) class III or IV congestive heart failure symptoms 4. Any previous coronary revascularization 5. Any individuals with: 1. Diabetes 2. Suspected unstable angina 3. Systemic infections 4. Systemic inflammatory conditions 6. Any individuals currently taking: 1. Steroids 2. Immunosuppressive agents 3. Chemotherapeutic agents 7. Recipient of any organ transplant</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Angina</keyword>
	<keyword>Molecular Genetics</keyword>
	<keyword>Atherosclerosis</keyword>
</DOC>